Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Parkinsonism & Related Disorders

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2015.11.023PMID 26639979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.

  2014cited by this paper
• Potential Subjects’ Responses to an Ethics Questionnaire in a Phase I Study of Deep Brain Stimulation in Early Parkinson’s Disease

  2012cited by this paper
• Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial.

  2012cited by this paper
• Fortitude and Community: Response to Yee and Ford

  2012cited by this paper
• Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial

  2011cited by this paper

• Expanding indications for deep brain stimulation

  2018cites this paper
• Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu4).

  2018cites this paper
• Discovery of VU2957 (Valiglurax): An mGlu4 Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's Disease.

  2018cites this paper
• New neurosurgical approaches for tremor and Parkinson's disease

  2017cites this paper
• Subthalamic nucleus deep brain stimulation on motor‐symptoms of Parkinson's disease: Focus on neurochemistry

  2017cites this paper
• Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid‐Stage Parkinson's Patients

  2017cites this paper